Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies
- PMID: 12559839
- DOI: 10.1006/nlme.2002.4099
Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies
Abstract
Drug addiction is characterized by a set of recurring processes (intoxication, withdrawal, craving) that lead to the relapsing nature of the disorder. We have used positron emission tomography to investigate in humans the role of dopamine (DA) and the brain circuits it regulates in these processes. We have shown that increases in DA are associated with the subjective reports of drug reinforcement corroborating the relevance of drug-induced DA increases in the rewarding effects of drugs in humans. During withdrawal we have shown in drug abusers significant reductions in DA D2 receptors and in DA release. We postulate that this hypodopaminergic state would result in a decreased sensitivity to natural reinforcers perpetuating the use of the drug as a means to compensate for this deficit and contributing to the anhedonia and dysphoria seen during withdrawal. Because the D2 reductions are associated with decreased activity in the anterior cingulate gyrus and in the orbitofrontal cortex we postulate that this is one of the mechanisms by which DA disruption leads to compulsive drug administration and the lack of control over drug intake in the drug-addicted individual. This is supported by studies showing that during craving these frontal regions become hyperactive in proportion to the intensity of the craving. Craving is also associated with activation of memory circuits including the amygdala (implicated in conditioned learning), hippocampus (implicated in declarative learning), and dorsal striatum (implicated in habit learning) all of which receive DA innervation. We therefore postulate that dopamine contributes to addiction by disrupting the frontal cortical circuits that regulate motivation, drive, and self-control and by memory circuits that increase the motivational salience of the drug and drug-associated stimuli.
Copyright 2002 Elsevier Science (USA)
Similar articles
-
Addiction: beyond dopamine reward circuitry.Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15037-42. doi: 10.1073/pnas.1010654108. Epub 2011 Mar 14. Proc Natl Acad Sci U S A. 2011. PMID: 21402948 Free PMC article. Review.
-
Dopamine in drug abuse and addiction: results of imaging studies and treatment implications.Arch Neurol. 2007 Nov;64(11):1575-9. doi: 10.1001/archneur.64.11.1575. Arch Neurol. 2007. PMID: 17998440 Review.
-
Dopamine in drug abuse and addiction: results from imaging studies and treatment implications.Mol Psychiatry. 2004 Jun;9(6):557-69. doi: 10.1038/sj.mp.4001507. Mol Psychiatry. 2004. PMID: 15098002 Review.
-
Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies.Behav Pharmacol. 2002 Sep;13(5-6):355-66. doi: 10.1097/00008877-200209000-00008. Behav Pharmacol. 2002. PMID: 12394411 Review.
-
Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex.Am J Psychiatry. 2002 Oct;159(10):1642-52. doi: 10.1176/appi.ajp.159.10.1642. Am J Psychiatry. 2002. PMID: 12359667 Free PMC article. Review.
Cited by
-
Social and physical anhedonia in relation to grandiose and vulnerable narcissism.Curr Issues Personal Psychol. 2021 Mar 25;9(1):46-52. doi: 10.5114/cipp.2021.104595. eCollection 2021. Curr Issues Personal Psychol. 2021. PMID: 38013696 Free PMC article.
-
Striatonigral direct pathway 2-arachidonoylglycerol contributes to ethanol effects on synaptic transmission and behavior.Neuropsychopharmacology. 2023 Dec;48(13):1941-1951. doi: 10.1038/s41386-023-01671-8. Epub 2023 Aug 1. Neuropsychopharmacology. 2023. PMID: 37528221 Free PMC article.
-
Meta-analytic evidence for a sex-diverging association between alcohol use and body mass index.Sci Rep. 2022 Dec 19;12(1):21869. doi: 10.1038/s41598-022-25653-w. Sci Rep. 2022. PMID: 36535973 Free PMC article.
-
Negative symptoms in alcohol use disorder: A pilot study applying the two-factor model of negative symptoms to patients with alcohol use disorder.Front Psychiatry. 2022 Nov 18;13:957924. doi: 10.3389/fpsyt.2022.957924. eCollection 2022. Front Psychiatry. 2022. PMID: 36479554 Free PMC article.
-
Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial.JCI Insight. 2022 Oct 10;7(19):e159863. doi: 10.1172/jci.insight.159863. JCI Insight. 2022. PMID: 36066977 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical